acute megakaryoblastic leukemia
GPTKB entity
Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
leukemia |
| gptkbp:abbreviation |
gptkb:AMKL
|
| gptkbp:affects |
megakaryoblasts
|
| gptkbp:associatedWith |
gptkb:Down_syndrome
|
| gptkbp:characterizedBy |
proliferation of megakaryoblasts
|
| gptkbp:commonIn |
children
infants |
| gptkbp:diagnosedBy |
bone marrow biopsy
immunophenotyping |
| gptkbp:firstDescribed |
1931
|
| https://www.w3.org/2000/01/rdf-schema#label |
acute megakaryoblastic leukemia
|
| gptkbp:ICD-10_code |
gptkb:C94.2
|
| gptkbp:marking |
gptkb:CD41
gptkb:CD42b gptkb:CD61 |
| gptkbp:riskFactor |
gptkb:Down_syndrome
genetic predisposition |
| gptkbp:subclassOf |
gptkb:acute_myeloid_leukemia
|
| gptkbp:symptom |
gptkb:anemia
bleeding hepatosplenomegaly thrombocytopenia |
| gptkbp:synonym |
gptkb:AML_M7
gptkb:acute_megakaryocytic_leukemia |
| gptkbp:treatment |
chemotherapy
hematopoietic stem cell transplantation |
| gptkbp:bfsParent |
gptkb:acute_myeloid_leukemia
|
| gptkbp:bfsLayer |
5
|